GlassScriptPhysician profile
Timothy Kuang
NPI 1134107550
$9,583.44
in general payments reported to CMS, 2019-2025
30 companies · $1,979 in 2025
The $1,979 reported for 2025 was more than what 86% of Pain Medicine (Physical Medicine & Rehabilitation) providers received nationally (typical 2025 total: $400).
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,297 · 2020: $706 · 2021: $1,059 · 2022: $889 · 2023: $1,335 · 2024: $2,320 · 2025: $1,979.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,218 · Education: $416.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,217.96 |
| Education | $416.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,176.06 | 2021-2025 | Accurian, Synchromedii, Intellis Adaptivestim |
| Biotronik Nro, INC. | $1,782.72 | 2024-2025 | Prospera |
| Tersera Therapeutics LLC | $919.67 | 2019-2024 | Prialt |
| Medtronic USA, INC. | $850.49 | 2019-2020 | |
| Boston Scientific Corporation | $679.49 | 2019-2025 | Intracept, Superion Indirect Decompression System |
| Vertiflex, INC. | $611.53 | 2019 | |
| Abbvie INC. | $409.46 | 2021-2025 | |
| Painteq LLC | $216.67 | 2022-2023 | Painteq |
| Pacira Pharmaceuticals Incorporated | $147.51 | 2020-2024 | Exparel |
| Abbott Laboratories | $94.28 | 2021 | |
| Allergan, INC. | $72.24 | 2019-2022 | |
| Foundation Fusion Solutions, LLC | $62.97 | 2023 | |
| Vertex Pharmaceuticals Incorporated | $56.37 | 2025 | |
| Almatica Pharma LLC | $48.48 | 2022 | |
| Si-Bone, INC. | $44.86 | 2019 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanos Medical | $42.80 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $42.41 | 2022-2023 | Ajovy |
| Nevro Corp. | $34.36 | 2023 | Senza |
| Depuy Synthes Sales INC. | $31.63 | 2022 | |
| Grt US Holding, INC. | $31.46 | 2021 | |
| Stryker Corporation | $29.42 | 2021 | |
| Relievant Medsystems, INC. | $28.09 | 2021 | |
| Ferring Pharmaceuticals INC. | $26.28 | 2023 | Euflexxa |
| Pfizer INC. | $24.02 | 2021 | |
| Scilex Pharmaceuticals INC. | $23.63 | 2022 | |
| Catalyst Pharmaceuticals, INC. | $22.86 | 2024 | |
| Amgen INC. | $21.97 | 2021 | |
| Supernus Pharmaceuticals, INC. | $20.05 | 2020 | |
| Horizon Therapeutics Plc | $17.71 | 2022 | |
| Lilly USA, LLC | $13.95 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Kuang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.